ArticleTranslational andrology and urology2019

Erectile dysfunction management after failed phosphodiesterase-5-inhibitor trial: a cost-effectiveness analysis.

Rachel A Moses et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.